⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mek 162 therapy or molecularly targeted therapy

Every month we try and update this database with for mek 162 therapy or molecularly targeted therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is MetastaticNCT02094872
Recurrent Melan...
Stage IIIA Mela...
Stage IIIB Mela...
Stage IIIC Mela...
Stage IV Melano...
cytology specim...
MEK 162 therapy...
therapeutic pro...
laboratory biom...
quality-of-life...
18 Years - Yale University
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is MetastaticNCT02094872
Recurrent Melan...
Stage IIIA Mela...
Stage IIIB Mela...
Stage IIIC Mela...
Stage IV Melano...
cytology specim...
MEK 162 therapy...
therapeutic pro...
laboratory biom...
quality-of-life...
18 Years - Yale University
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is MetastaticNCT02094872
Recurrent Melan...
Stage IIIA Mela...
Stage IIIB Mela...
Stage IIIC Mela...
Stage IV Melano...
cytology specim...
MEK 162 therapy...
therapeutic pro...
laboratory biom...
quality-of-life...
18 Years - Yale University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: